Literature DB >> 8484694

Detection of Luse bodies, spiralled collagen, dysplastic collagen, and intracellular collagen in rheumatoid connective tissues: an electron microscopic study.

M F Neurath1.   

Abstract

BACKGROUND: Rheumatoid arthritis is a chronic inflammatory disease leading to alterations of the extracellular matrix in tendons, ligaments, and cartilage. The structural changes of the collagenous systems in rheumatoid connective tissues are largely unknown, however.
METHODS: Thirty four samples of menisci, 36 cruciate ligaments, and four tendons were taken during joint surgery in patients with rheumatoid arthritis. Eighteen menisci, 35 ligaments, and 30 tendons obtained at necropsy served as a control group. The extracellular matrix in the two groups was analysed by the combined use of transmission and scanning electron microscopy, immunohistochemistry with monoclonal antibodies recognising collagen types IV and VI, and ultramorphometry.
RESULTS: Normal tendons and ligaments predominantly showed a unidirectional fibril arrangement. Whereas type IV collagen showed a positive staining pattern along all basement membranes, type VI collagen formed fine, filaments aligned in parallel. In patients with rheumatoid arthritis a significant reduction of the mean diameter of the collagen fibrils was found owing to the presence of thin collagenous fibrils 20-60 nm in diameter. Most of these fibrils showed considerable changes in their arrangement with irregular courses (so-called interfibrillar dysplastic collagen). Up to 410 nm thick frayed fibrils with irregular outlines (spiralled collagen) and intracellular collagen forms were found in rheumatoid tissues. In addition, atypical thick collagenous structures with 41 nm periodicity (Luse bodies) were detected in the matrix. The upregulation of type IV collagen in rheumatoid arthritis was associated with an increase in the vascular density. The expression of type VI collagen was upregulated in fibrotic zones.
CONCLUSIONS: The dramatic ultrastructural collagen changes lead to a structural and functional insufficiency of the extracellular matrix in rheumatoid connective tissues. The results suggest that collagen alterations may contribute to the development of tendon and ligament ruptures in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484694      PMCID: PMC1005626          DOI: 10.1136/ard.52.4.278

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

Review 1.  Molecules of the extracellular matrix: potential role of collagens and glycoproteins in intestinal adaptation.

Authors:  D Schuppan; E O Riecken
Journal:  Digestion       Date:  1990       Impact factor: 3.216

2.  Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function.

Authors:  J A Madri; M D Basson
Journal:  Lab Invest       Date:  1992-05       Impact factor: 5.662

3.  Distribution of type VI collagen expression in synovial tissue and cultured synoviocytes: relation to fibronectin expression.

Authors:  J Wolf; S E Carsons
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

4.  Joint destruction in arthritis: metalloproteinases in the spotlight.

Authors:  C E Brinckerhoff
Journal:  Arthritis Rheum       Date:  1991-09

Review 5.  Metalloproteinases and their inhibitors in matrix remodeling.

Authors:  L M Matrisian
Journal:  Trends Genet       Date:  1990-04       Impact factor: 11.639

6.  Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium.

Authors:  S S McCachren
Journal:  Arthritis Rheum       Date:  1991-09

7.  In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium.

Authors:  E M Gravallese; J M Darling; A L Ladd; J N Katz; L H Glimcher
Journal:  Arthritis Rheum       Date:  1991-09

8.  Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids.

Authors:  G S Firestein; M M Paine; B H Littman
Journal:  Arthritis Rheum       Date:  1991-09

9.  Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.

Authors:  L A Walakovits; V L Moore; N Bhardwaj; G S Gallick; M W Lark
Journal:  Arthritis Rheum       Date:  1992-01

10.  The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study.

Authors:  G R Dodge; I Pidoux; A R Poole
Journal:  Matrix       Date:  1991-11
View more
  4 in total

1.  Complementary roles of intracellular and pericellular collagen degradation pathways in vivo.

Authors:  Rebecca A Wagenaar-Miller; Lars H Engelholm; Julie Gavard; Susan S Yamada; J Silvio Gutkind; Niels Behrendt; Thomas H Bugge; Kenn Holmbeck
Journal:  Mol Cell Biol       Date:  2007-07-09       Impact factor: 4.272

2.  Collagenous microstructure of the glenoid labrum and biceps anchor.

Authors:  A M Hill; E J Hoerning; K Brook; C D Smith; J Moss; T Ryder; A L Wallace; A M J Bull
Journal:  J Anat       Date:  2008-04-21       Impact factor: 2.610

3.  M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway.

Authors:  Daniel H Madsen; Daniel Leonard; Andrius Masedunskas; Amanda Moyer; Henrik Jessen Jürgensen; Diane E Peters; Panomwat Amornphimoltham; Arul Selvaraj; Susan S Yamada; David A Brenner; Sven Burgdorf; Lars H Engelholm; Niels Behrendt; Kenn Holmbeck; Roberto Weigert; Thomas H Bugge
Journal:  J Cell Biol       Date:  2013-09-09       Impact factor: 10.539

4.  Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.

Authors:  Alejandro C Curino; Lars H Engelholm; Susan S Yamada; Kenn Holmbeck; Leif R Lund; Alfredo A Molinolo; Niels Behrendt; Boye Schnack Nielsen; Thomas H Bugge
Journal:  J Cell Biol       Date:  2005-06-20       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.